The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type <i>IDH</i>, Unmethylated MGMT<i>p</i> Glioblastoma During the COVID-19 Pandemic
David Kamson, Stuart A. Grossman
Topics & Concepts
TemozolomideMedicineGlioblastomaPandemicCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OncologyInternal medicineCancer researchDiseaseOutbreakInfectious disease (medical specialty)Glioma Diagnosis and TreatmentBrain Metastases and TreatmentRadiomics and Machine Learning in Medical Imaging